The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Regulatory News (CYN)

Share Price Information for CQS Natural Resources (CYN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 187.50
Bid: 187.50
Ask: 191.00
Change: 0.50 (0.27%)
Spread: 3.50 (1.867%)
Open: 188.00
High: 188.00
Low: 187.50
Prev. Close: 187.00
CYN Live PriceLast checked at -
CQS Natural Resources Growth & Income is an Investment Trust

To provide shareholders with capital growth and income predominantly from a portfolio of mining and resource equities and of mining, resource and industrial fixed interest securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investor Report - September

19 Oct 2023 09:33

RNS Number : 6719Q
CQS Natural Resources Grwth&Inc PLC
19 October 2023

CQS Natural Resources Growth & Income Plc

Monthly Investor Report - September

The full monthly factsheet is now available on the Company's website and a summary can be found below.

https://ncim.co.uk/wp/city-natural-resources-high-yield-trust

Enquiries:

For the Investment Manager

CQS (UK) LLP

Craig Cleland

0207 201 5368

For the Company Secretary and Administrator

BNP Paribas S.A., Jersey Branch

Dean Plowman

01534 813 967

-----------------------------------------------------------------------

Fund Description

The Fund aims to generate capital growth and income, predominantly from a portfolio of mining and resource equities, and from mining, resource and industrial fixed interest securities.

Portfolio Managers

Ian Francis, Keith Watson, and Robert Crayfourd

Key Advantages for the Investor

· Access to under-researched, mid and smaller-cap companies in the global Natural Resources sector

· Quarterly dividend paid to shareholders

· Potential inflation hedge

Key Fund Facts1

Total Gross Assets

£153.72m

Reference Currency

GBP

Ordinary Shares:

Net Asset Value

210.66p

Mid-Market Price

179.50p

Dividend Yield (estimated)

3.1%

Net gearing4

9.1%

Discount

(14.79%)

Ordinary Share and NAV Performance2

One Month

Three Months

Six Months

One Year

Three Years

Five Years

Since Inception

(%)

(%)

(%)

(%)

(%)

(%)

(%)

NAV

1.2

5.8

2.6

1.0

113.6

100.9

626.8

Share Price

3.4

8.8

5.8

4.4

119.1

116.0

585.9

Commentary3

Market Supported by continued OPEC+ discipline, which also saw Russian overproduction being reined in, energy prices rose substantially during September, continuing to outpace the lacklustre performance of more cyclically sensitive Industrial metals. While the US FED held rates in September, the energy price strength is more broadly sustaining pressure on central banks to maintain hawkish, stronger-for-longer guidance on rates. Against a backdrop in which China has continued to reduce its holdings of US treasuries, US 10yr yields moved higher and the US Dollar Index strengthened around 2.5%.

Brent and WTI crude prices increased nearly 9% and 10% respectively as Saudi Arabia and Russia agreed to extend voluntary production cuts to the year end. The threat of strikes at Australian LNG facilities saw natural gas benchmarks in Europe and Asia rise 21% and 10% respectively though US benchmarks slipped due to mild temperatures. Coal proved resilient with strong demand arising from India, potentially reflecting strike risks at some of the country's mining operations. Alongside this, potential supply disruption risks from an increase in mine safety checks in China may also have contributed to price resilience, helping counter record production from Mongolia which reported a sharp jump in output which totaled 45Mt year to end-Aug, +184% year-on-year. Momentum in the resurgent nuclear power market picked-up during September's World Nuclear Association gathering. The U3O8 price jumped 22% during the month as utility buyers seek to secure long-term contracts, while the physically backed Sprott Physical Uranium Trust also returned to a premium allowing it to raise funds and purchase material.

Sustained US dollar strength, uninspiring Chinese economic data and ongoing concerns regarding the poor health of China's property sector saw copper end the month around 2% lower. The seaborne iron ore price held up, registering a 1.7% rise, as strong import demand from India also supported prices. This allowed the iron ore price to shrug off expectations of lower Chinese demand with indicated steel production limits for 2023 implying a reduction in regional ore consumption over the remainder of the year. The price of steel input nickel declined 7% with the latest monthly data from the International Nickel Study Group indicating mine output rose 17% on the prior year, well ahead of demand and implying a surplus of metal. Precious metal prices remained extremely sensitive to the outlook for interest rates and gold ended September nearly 5% lower. Despite the more positive energy pricing, E&P stocks closed the month little changed, copper mining equities slipped a modest 4%, while precious metal indices lost around 19% over the month.

Performance

Reflecting positive revenue receipts from dividend payments the Trust made a 3p per share special dividend which together with sterling's relative softness helped generate a total return of 3.1% for the month. The Fund NAV was little changed over the month. Strong positive contributions were made by tier 1 uranium mine developer NexGen, gold producer Emerald Resources and shipper BW LPG, whose share prices rose 19%, 18% and 8% respectively in sterling terms. The brief removal of Leo Lithium from suspension, as discussed last month, saw the shares halve, which unfortunately offset these gains, prior to being suspended again at the month-end, pending a further update on developments with the government.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDMLBPTMTJBMTJ
Date   Source Headline
29th Apr 20245:30 pmRNSTransaction in Own Shares
29th Apr 202412:52 pmRNSNet Asset Value(s)
26th Apr 20245:10 pmRNSTransaction in Own Shares
26th Apr 20244:41 pmRNSHolding(s) in Company
26th Apr 20242:19 pmRNSNet Asset Value(s)
26th Apr 20241:25 pmRNSMonthly Fact Sheet as at 31 March 2024
25th Apr 20245:19 pmRNSTransaction in Own Shares
25th Apr 20242:53 pmRNSNet Asset Value(s)
24th Apr 20246:27 pmRNSTransaction in Own Shares
24th Apr 20241:29 pmRNSNet Asset Value(s)
23rd Apr 202412:08 pmRNSNet Asset Value(s)
22nd Apr 20242:01 pmRNSNet Asset Value(s)
19th Apr 202412:56 pmRNSNet Asset Value(s)
18th Apr 20242:19 pmRNSNet Asset Value(s)
17th Apr 202411:32 amRNSNet Asset Value(s)
16th Apr 202412:32 pmRNSNet Asset Value(s)
15th Apr 20241:56 pmRNSNet Asset Value(s)
12th Apr 20241:03 pmRNSNet Asset Value(s)
11th Apr 20243:51 pmRNSNet Asset Value(s)
11th Apr 202412:09 pmRNSHolding(s) in Company
10th Apr 20243:02 pmRNSNet Asset Value(s)
10th Apr 202410:37 amRNSDividend Declaration
9th Apr 20243:01 pmRNSNet Asset Value(s)
9th Apr 20242:04 pmRNSHolding(s) in Company
9th Apr 202411:45 amRNSHolding(s) in Company
8th Apr 20241:25 pmRNSNet Asset Value(s)
5th Apr 20242:03 pmRNSNet Asset Value(s)
5th Apr 20241:45 pmRNSHolding(s) in Company
4th Apr 202412:43 pmRNSNet Asset Value(s)
3rd Apr 20243:19 pmRNSDirector/PDMR Shareholding
3rd Apr 202412:39 pmRNSNet Asset Value(s)
3rd Apr 20249:00 amRNSInvestment Manager
2nd Apr 20242:15 pmRNSNet Asset Value(s)
2nd Apr 20241:25 pmRNSDirector/PDMR Shareholding
28th Mar 20243:57 pmRNSHolding(s) in Company
28th Mar 20242:38 pmRNSNet Asset Value(s)
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 202412:13 pmRNSNet Asset Value(s)
26th Mar 202411:17 amRNSNet Asset Value(s)
25th Mar 202412:29 pmRNSNet Asset Value(s)
22nd Mar 20241:49 pmRNSNet Asset Value(s)
21st Mar 20241:32 pmRNSNet Asset Value(s)
20th Mar 20241:08 pmRNSNet Asset Value(s)
19th Mar 202412:16 pmRNSNet Asset Value(s)
19th Mar 20249:12 amRNSMonthly Fact Sheet as at 29 February 2024
18th Mar 20241:17 pmRNSNet Asset Value(s)
15th Mar 20241:40 pmRNSNet Asset Value(s)
14th Mar 20241:52 pmRNSNet Asset Value(s)
13th Mar 20241:42 pmRNSNet Asset Value(s)
12th Mar 20244:21 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.